BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 19749365)

  • 1. An isostructural G-G to A-A substitution within the HIV RRE RNA switches the specificity towards arginine-rich peptides.
    Aoyama S; Sugaya M; Kobayashi C; Masuda K; Maeda T; Sakamoto T; Kawai G; Katoh A; Harada K
    Nucleic Acids Symp Ser (Oxf); 2009; (53):271-2. PubMed ID: 19749365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino acid requirement for the high affinity binding of a selected arginine-rich peptide with the HIV Rev-response element RNA.
    Sugaya M; Nishino N; Katoh A; Harada K
    J Pept Sci; 2008 Aug; 14(8):924-35. PubMed ID: 18351707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exchange of the basic domain of human immunodeficiency virus type 1 Rev for a polyarginine stretch expands the RNA binding specificity, and a minimal arginine cluster is required for optimal RRE RNA binding affinity, nuclear accumulation, and trans-activation.
    Nam YS; Petrovic A; Jeong KS; Venkatesan S
    J Virol; 2001 Mar; 75(6):2957-71. PubMed ID: 11222721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The amino terminal domain of HIV-1 Rev is required for discrimination of the RRE from nonspecific RNA.
    Daly TJ; Doten RC; Rusche JR; Auer M
    J Mol Biol; 1995 Oct; 253(2):243-58. PubMed ID: 7563086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arginine side-chain dynamics in the HIV-1 rev-RRE complex.
    Wilkinson TA; Botuyan MV; Kaplan BE; Rossi JJ; Chen Y
    J Mol Biol; 2000 Nov; 303(4):515-29. PubMed ID: 11054288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide-triggered conformational switch in HIV-1 RRE RNA complexes.
    Gosser Y; Hermann T; Majumdar A; Hu W; Frederick R; Jiang F; Xu W; Patel DJ
    Nat Struct Biol; 2001 Feb; 8(2):146-50. PubMed ID: 11175904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of HIV Rev peptides with the Rev response element RNA.
    Williamson JR; Battiste JL; Mao H; Frankel AD
    Nucleic Acids Symp Ser; 1995; (33):46-8. PubMed ID: 8643394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescence-based methods for evaluating the RNA affinity and specificity of HIV-1 Rev-RRE inhibitors.
    Luedtke NW; Tor Y
    Biopolymers; 2003 Sep; 70(1):103-19. PubMed ID: 12925996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Water, shape recognition, salt bridges, and cation-pi interactions differentiate peptide recognition of the HIV rev-responsive element.
    Michael LA; Chenault JA; Miller BR; Knolhoff AM; Nagan MC
    J Mol Biol; 2009 Sep; 392(3):774-86. PubMed ID: 19631217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A non-canonical base pair within the human immunodeficiency virus rev-responsive element is involved in both rev and small molecule recognition.
    Werstuck G; Zapp ML; Green MR
    Chem Biol; 1996 Feb; 3(2):129-37. PubMed ID: 8807838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diverse mutants of HIV RRE IIB recognize wild-type Rev ARM or Rev ARM R35G-N40V.
    Abdallah EY; Smith CA
    J Mol Recognit; 2015 Dec; 28(12):710-21. PubMed ID: 26130028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element.
    Luedtke NW; Liu Q; Tor Y
    Biochemistry; 2003 Oct; 42(39):11391-403. PubMed ID: 14516190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural analysis of ribonucleopeptide aptamer against ATP.
    Mashima T; Matsugami A; Nakano S; Inoue M; Fukuda M; Morii T; Katahira M
    Nucleic Acids Symp Ser (Oxf); 2009; (53):267-8. PubMed ID: 19749363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized codon mutagenesis reveals that the HIV Rev arginine-rich motif is robust to substitutions and that double substitution of two critical residues alters specificity.
    Possik EJ; Bou Sleiman MS; Ghattas IR; Smith CA
    J Mol Recognit; 2013 Jun; 26(6):286-96. PubMed ID: 23595810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolvability of the mode of peptide binding by an RNA.
    Iwazaki T; Li X; Harada K
    RNA; 2005 Sep; 11(9):1364-73. PubMed ID: 16043495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural dynamics of HIV-1 Rev and its complexes with RRE and 5S RNA.
    Lam WC; Seifert JM; Amberger F; Graf C; Auer M; Millar DP
    Biochemistry; 1998 Feb; 37(7):1800-9. PubMed ID: 9485305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manipulation of the peptide-binding specificity of an RNA in a rational manner by combinations of specificity-altering mutations.
    Harada K; Sugaya M; Nishimura F; Katoh A
    Nucleic Acids Symp Ser (Oxf); 2008; (52):13-4. PubMed ID: 18776229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural change in Rev responsive element RNA of HIV-1 on binding Rev peptide.
    Peterson RD; Feigon J
    J Mol Biol; 1996 Dec; 264(5):863-77. PubMed ID: 9000617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dynamic in vivo view of the HIV-I Rev-RRE interaction.
    Charpentier B; Stutz F; Rosbash M
    J Mol Biol; 1997 Mar; 266(5):950-62. PubMed ID: 9086273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity in the binding of aminoglycosides to HIV-RRE RNA.
    Cho J; Rando RR
    Biochemistry; 1999 Jun; 38(26):8548-54. PubMed ID: 10387102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.